BlackRock Japan’s Enanta Pharmaceuticals ENTA Stock Holding History

BlackRock Japan’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$14K	Sell	430 -131	-23%	-$3.75K	﹤0.01%	1181
2016 Q3	$15K	Hold	561	–	–	﹤0.01%	1160
2016 Q2	$12K	Sell	561 -22,676	-98%	-$594K	﹤0.01%	1251
2016 Q1	$682K	Sell	23,237 -11,180	-32%	-$311K	﹤0.01%	729
2015 Q4	$1.14M	Sell	34,417 -684	-2%	-$22.3K	﹤0.01%	706
2015 Q3	$1.27M	Sell	35,101 -14,115	-29%	-$606K	0.01%	693
2015 Q2	$2.21M	Sell	49,216 -1,617	-3%	-$62.9K	0.01%	695
2015 Q1	$1.56M	Buy	50,833 +6,098	+14%	+$237K	0.01%	710
2014 Q4	$2.27M	Buy	44,735 +43,018	+2,505%	+$1.93M	0.01%	683
2014 Q3	$68K	Buy	1,717 +501	+41%	+$20K	﹤0.01%	1008
2014 Q2	$52K	Buy	+1,216	New	+$46.4K	﹤0.01%	1028

Other funds holding ENTA

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's ENTA Position: Q4 2016 in Review

BlackRock Japan reduced its Enanta Pharmaceuticals (ENTA) stake by 23% in Q4 2016, selling an estimated $3.75K and leaving 430 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1181.

BlackRock Japan first reported a position in ENTA in Q2 2014 and has held it in 11 quarters since. The position peaked at $2.27M in Q4 2014. 149 funds tracked by Wall St. Rank hold ENTA as of Q4 2016.

BlackRock Japan held 430 shares of Enanta Pharmaceuticals worth $14K as of Q4 2016.
BlackRock Japan sold 131 Enanta Pharmaceuticals shares in Q4 2016, an estimated $3.75K.
Enanta Pharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1181 holding.
BlackRock Japan first reported a position in Enanta Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Japan's Enanta Pharmaceuticals position peaked at $2.27M in Q4 2014.
149 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.